Prolonged Suppression of Tinnitus After Peripheral Nerve Block Using Bupivacaine and Lidocaine

Weinmeister, Kent P.

doi:10.1097/00115550-200001000-00012

Cited by 8 publications

(1 citation statement)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Weinmeister hingegen beschreibt als nichtintendierte Nebenwirkung eine Tinnitusunterdrückung bei einer Lokalanäs-thesie [28].In diesem Sinne werden HNOärztlich Lidocaininfusionen (meist 100 mg über 5 min) eingesetzt [29], um den Tinnitus zu mindern. Dies hat bei 50% der Infundierten für die Zeit der Infusionsgabe Erfolg.…”

Section: Tinnitus Und Hörstörungen Nach Lokalanästhesieunclassified

Tinnitus nach An�sthesie

Schaaf¹,

Kampe

Hesse³

2004

Anaesthesist

View full text Add to dashboard Cite

Possible connections between different forms of anaesthesia and the occurrence of tinnitus or increasing levels of tinnitus are described. After general anaesthesia no increase in the occurrence or level of tinnitus is to be expected, but there exists a very rare, but specific form of low frequency tinnitus combined with low frequency sensory hearing loss following spinal anaesthesia. Reversible tinnitus and hearing disorders following local anaesthesia normally occur in cases of central nervous system toxicity.

show abstract

Section: Tinnitus Und Hörstörungen Nach Lokalanästhesieunclassified

Tinnitus nach An�sthesie

Schaaf¹,

Kampe

Hesse³

2004

Anaesthesist

View full text Add to dashboard Cite

show abstract

References

2013

Tinnitus: A Multidisciplinary Approach

View full text Add to dashboard Cite

Effects of ropivacaine on transient-evoked otoacoustic emissions: a rabbit model

Arıkan

Muluk

Budak

et al. 2006

Eur Arch Otorhinolaryngol

View full text Add to dashboard Cite

The aim of this study was to investigate the effect of ropivacaine, a newer amide local anesthetic, on the ears of rabbits by using transient-evoked otoacoustic emissions (TEOAEs). Thirty rabbits were studied in a random block design of six groups of five animals each. There received intra-tympanically instilled single doses of 0.5 mg/kg, 1.0 mg/kg of ropivacaine, 0.5 ml of isotonic saline (control for intratympanic application), or intravenously administered single doses of 1.0 mg/kg, 2.0 mg/kg of ropivacaine and 1.0 ml of isotonic saline (control for intravenous application). Cochlear function was serially monitored using TEOAEs before administration and on the 1st and 15th days after administrations of ropivacaine or isotonic saline. The responses of TEOAEs were analyzed in terms of mean stimulus, stability, wave reproducibility and emission amplitudes at 1.0-4.0 kHz. We found no significant changes in the TEOAE responses of the baseline measurements in each group before administration and the responses at each interval in the same group after administration throughout the experiment (P > 0.05). Also, no significant difference was found between the group receiving ropivacaine administered intravenously or intratympanicly and the control group at each interval (P > 0.05). The data from the present study showed that ropivacaine, whether administered intravenously or intratympanically and even at a low or high dose, has no effects on the responses of TEOAEs in the early period. These findings encourage the use of ropivacaine as a safe agent without ototoxic effects in peripheral nerve blocks, epidural and intravenous regional anesthesia or even tinnitus therapy in the future.

show abstract

Prolonged Suppression of Tinnitus After Peripheral Nerve Block Using Bupivacaine and Lidocaine

Cited by 8 publications

References 7 publications

Tinnitus nach An�sthesie

Tinnitus nach An�sthesie

References

Effects of ropivacaine on transient-evoked otoacoustic emissions: a rabbit model

Contact Info

Product

Resources

About